SCHEMBL28229241

SCHEMBL28229241

CN(C)C(C(=O)O)c1ccc(CN)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
LOXL2 Q9Y4K0 1/20 0.41
BACE1 P56817 2/20 0.40
PTGS1 P23219 4/20 0.40
PTGS2 P35354 4/20 0.40
LMNA P02545 2/20 0.40
CYP2C9 P11712 2/20 0.40
AKR1C3 P42330 2/20 0.40
CXCR1 P25024 2/20 0.40
CXCR2 P25025 2/20 0.40
ALB P02768 1/20 0.40
ESR1 P03372 1/20 0.40
ALOX5 P09917 1/20 0.40
RARB P10826 1/20 0.40
ADRB3 P13945 1/20 0.40
NFKB1 P19838 1/20 0.40
HTR2A P28223 1/20 0.40
NR1I3 Q14994 1/20 0.40
SLC22A6 Q4U2R8 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28229240 1.00 KDM4E (0.42) KDM4ESMN1; SMN2LOXL2BACE1PTGS1
SCHEMBL28229182 0.83 CYP2D6 (0.44) SMN1; SMN2LOXL2CYP2C9NFKB1TSHR
SCHEMBL28229181 0.83 CYP2D6 (0.44) SMN1; SMN2LOXL2CYP2C9NFKB1TSHR
SCHEMBL18920459 0.77 CHRNA7 (0.50) SMN1; SMN2LMNAALOX5
SCHEMBL18920460 0.77 CHRNA7 (0.50) SMN1; SMN2LMNAALOX5
SCHEMBL18946105 0.77 CHRNA7 (0.50) SMN1; SMN2LMNAALOX5
SCHEMBL1960706 0.77 SRC (0.46) PTGS1LMNACYP2C9ESR1CYP2D6
SCHEMBL10933400 0.77 SRC (0.46) PTGS1LMNACYP2C9ESR1CYP2D6
SCHEMBL628680 0.77 ALDH1A1 (0.51) KDM4ELMNAALOX5CYP2D6
SCHEMBL222001 0.77 ALDH1A1 (0.51) KDM4ELMNAALOX5CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108349965-A 1,3,4- thiadiazole compounds and its purposes in treating cancer 阿斯利康(瑞典)有限公司 2018-07-31 CN disclosed